Table 3 Estimated costs over 10 years for scenario B
From: Economic efficiency of primary care for CVD prevention and treatment in Eastern European countries
Group of patient | B1 | B2 | B3 | Max lost income |
|---|---|---|---|---|
HBP | 25658.90 | 107336.95 | 182548.30 | 35557.24 |
HBL | 25658.90 | 107336.95 | 182548.30 | 35557.24 |
HBS | 10565.43 | 85828.75 | 161040.10 | 35557.24 |
HBP and HBL | 48299.10 | 139599.23 | 214810.58 | 35557.24 |
HBP and HBS | 33205.63 | 118091.04 | 193302.39 | 35557.24 |
HBP and HBL and HBS | 55845.83 | 150353.33 | 225564.68 | 35557.24 |
Average costs | 33205.63 | 118091.04 | 193302.39 | 35557.24 |